Literature DB >> 18228512

Production of papillomavirus-based gene transfer vectors.

Christopher B Buck1, Cynthia D Thompson.   

Abstract

Papillomaviruses are a diverse group of pathogens that infect the skin and mucosal tissues of humans and various animal species. The viral genome is a circular, double-stranded DNA molecule approximately 8-kb in length. The non-enveloped papillomavirus capsid is composed of a virally encoded major coat protein, L1, and a minor coat protein, L2. L1 and L2 co-assemble when expressed in mammalian cells, and can promiscuously encapsidate essentially any <8-kb plasmid present in the cell nucleus. In the last several years, there has been rapid development of techniques for intracellular production of papillomavirus-based gene transfer vectors (also known as pseudoviruses). This unit outlines the production and propagative amplification of papillomaviral vectors. The system represents a highly tractable method for converting pre-existing mammalian expression plasmids into infectious virus stocks. The resulting vectors have utility for in vitro, as well as in vivo gene delivery applications. (c) 2007 by John Wiley & Sons, Inc.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18228512     DOI: 10.1002/0471143030.cb2601s37

Source DB:  PubMed          Journal:  Curr Protoc Cell Biol        ISSN: 1934-2616


  102 in total

1.  Human papillomavirus capsids preferentially bind and infect tumor cells.

Authors:  Rhonda C Kines; Rebecca J Cerio; Jeffrey N Roberts; Cynthia D Thompson; Elisabet de Los Pinos; Douglas R Lowy; John T Schiller
Journal:  Int J Cancer       Date:  2015-10-27       Impact factor: 7.396

2.  A human papillomavirus (HPV) in vitro neutralization assay that recapitulates the in vitro process of infection provides a sensitive measure of HPV L2 infection-inhibiting antibodies.

Authors:  Patricia M Day; Yuk-Ying S Pang; Rhonda C Kines; Cynthia D Thompson; Douglas R Lowy; John T Schiller
Journal:  Clin Vaccine Immunol       Date:  2012-05-16

3.  Inhibition of gamma secretase blocks HPV infection.

Authors:  Hao-Shun Huang; Christopher B Buck; Paul F Lambert
Journal:  Virology       Date:  2010-09-28       Impact factor: 3.616

4.  Infectious Entry of Merkel Cell Polyomavirus.

Authors:  Miriam Becker; Melissa Dominguez; Lilo Greune; Laura Soria-Martinez; Moritz M Pfleiderer; Rachel Schowalter; Christopher B Buck; Bärbel S Blaum; M Alexander Schmidt; Mario Schelhaas
Journal:  J Virol       Date:  2019-03-05       Impact factor: 5.103

5.  A paper-based immunoassay to determine HPV vaccination status at the point-of-care.

Authors:  Benjamin D Grant; Chelsey A Smith; Philip E Castle; Michael E Scheurer; Rebecca Richards-Kortum
Journal:  Vaccine       Date:  2016-09-22       Impact factor: 3.641

Review 6.  Concepts of papillomavirus entry into host cells.

Authors:  Patricia M Day; Mario Schelhaas
Journal:  Curr Opin Virol       Date:  2013-12-14       Impact factor: 7.090

7.  Human Papillomavirus Major Capsid Protein L1 Remains Associated with the Incoming Viral Genome throughout the Entry Process.

Authors:  Stephen DiGiuseppe; Malgorzata Bienkowska-Haba; Lucile G M Guion; Timothy R Keiffer; Martin Sapp
Journal:  J Virol       Date:  2017-07-27       Impact factor: 5.103

8.  Vaccine synergy with virus-like particle and immune complex platforms for delivery of human papillomavirus L2 antigen.

Authors:  Andrew G Diamos; Dalia Larios; Lauren Brown; Jacquelyn Kilbourne; Hyun Soon Kim; Divyasha Saxena; Kenneth E Palmer; Hugh S Mason
Journal:  Vaccine       Date:  2018-11-17       Impact factor: 3.641

9.  In vitro inhibition of human papillomavirus following use of a carrageenan-containing vaginal gel.

Authors:  Akiva P Novetsky; Marla J Keller; Ana Gradissimo; Zigui Chen; Stephanie L Morgan; Xiaonan Xue; Howard D Strickler; José A Fernández-Romero; Robert Burk; Mark H Einstein
Journal:  Gynecol Oncol       Date:  2016-09-10       Impact factor: 5.482

10.  Two highly conserved cysteine residues in HPV16 L2 form an intramolecular disulfide bond and are critical for infectivity in human keratinocytes.

Authors:  Samuel K Campos; Michelle A Ozbun
Journal:  PLoS One       Date:  2009-02-13       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.